← Back
Data updated: Mar 10, 2026
CAPLIN ONE LABS
OncologyImmunology
CAPLIN ONE LABS is a pharmaceutical company focused on Oncology, Immunology. Key products include BORTEZOMIB.
2006
Since
4
Drugs
-
Trials
39
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METHOTREXATE SODIUM PRESERVATIVE FREE 2026-01-14
Labeling
METHOTREXATE SODIUM PRESERVATIVE FREE 2026-01-14
Labeling
BORTEZOMIB 2026-01-06
BORTEZOMIB 2025-12-17
METHOTREXATE SODIUM PRESERVATIVE FREE 2025-08-18
Labeling
METHOTREXATE SODIUM PRESERVATIVE FREE 2025-08-18
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-14
Labeling
TESTOSTERONE CYPIONATE 2025-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
1 drugs
Immunology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2006-08-10
- Latest
- 2025-07-11
- Applications
- 5